Medical records from a little-known company were used in two studies published in major journals. The New England Journal of Medicine has asked to see the data.
Tag: Lancet, The (Journal)
Scientists Question Major Hydroxychloroquine Study
Experts demanded verification of data and methods used in a study of drugs to treat Covid-19. The study suggested the drugs might have increased deaths.
Scientists Question Validity of Major Hydroxychloroquine Study
Experts are demanding verification of data and methods used in a study of malaria drugs used to treat Covid-19. The study suggested the drugs may have increased deaths.
Coronavirus Vaccine Shows Promising Early Results in China
A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
Malaria Drug Taken by Trump Is Tied to Increased Risk of Heart Problems and Death in New Study
The drugs did not help coronavirus patients, and should not be used outside clinical trials, researchers said.
New Inflammatory Condition in Children Probably Linked to Coronavirus, Study Finds
Researchers compared 10 cases in Italy with previous cases of a similar childhood illness, Kawasaki disease. The rate of the new cases was much higher, and the conditions were more serious.
Effects of Coronavirus Begin Echoing Far From Wuhan Epicenter
Hong Kong closed its schools for several weeks, Beijing began limiting bus travel in and out of the capital and China’s travel association suspended tour groups of citizens heading overseas.
Effects of Coronavirus Begin Echoing Far From Wuhan Epicenter
Hong Kong closed its schools for several weeks, Beijing began limiting bus travel in and out of the capital and China’s travel association suspended tour groups of citizens heading overseas.
Climate Change Poses Threats to Children’s Health Worldwide
A study from the Lancet points to infectious diseases, worsening air pollution, rising temperatures and even malnutrition as threats to child health as the climate changes.
This Daily Pill Cut Heart Attacks by Half. Why Isn’t Everyone Getting It?
“Polypills” of generic drugs may dramatically reduce heart attacks and strokes in poor countries, a new study suggests. Some experts still aren’t enthusiastic.